COMPOUNDS THAT INHIBIT THE MCL-1 PROTEIN
CY1125734T1Undetermined Publication Date: 2026-04-17AMGEN INC
View PDF 0 Cites 0 Cited by
Patent Information
- Application Number
- CY20231100030T
- Authority / Receiving Office
- CY · CY
- Patent Type
- Patents
- Current Assignee / Owner
- Priority Date
- 2017-03-30
- Filing Date
- 2023-01-19
- Publication Date
- 2026-04-17
- Estimated Expiration
- 2043-01-19
Abstract
Provided herein are myeloid leukemia protein 1 (Mcl-1) inhibitors, methods for their preparation, related pharmaceutical compositions, and methods of use thereof. For example, provided herein are compounds of Formula (I), or a stereoisomer thereof, and pharmaceutically acceptable salts thereof, and pharmaceutical compositions containing the compounds. The compounds and compositions provided herein may be used, for example, in the treatment of diseases or conditions, such as cancer.
Need to check novelty before this filing date? Find Prior Art